[go: up one dir, main page]

ATA77096A - Pharmazeutische präparation - Google Patents

Pharmazeutische präparation

Info

Publication number
ATA77096A
ATA77096A AT77096A AT77096A ATA77096A AT A77096 A ATA77096 A AT A77096A AT 77096 A AT77096 A AT 77096A AT 77096 A AT77096 A AT 77096A AT A77096 A ATA77096 A AT A77096A
Authority
AT
Austria
Prior art keywords
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
AT77096A
Other languages
English (en)
Other versions
AT404554B (de
Inventor
Miha Dr Furlan
Bernhard Dr Laemmle
Hans Peter Dr Schwarz
Peter Dr Turecek
Johann Dr Eibl
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Priority to AT77096A priority Critical patent/AT404554B/de
Priority to US08/656,589 priority patent/US6068838A/en
Priority to DK97921765T priority patent/DK0907724T3/da
Priority to PT97921765T priority patent/PT907724E/pt
Priority to PCT/EP1997/002131 priority patent/WO1997041206A2/en
Priority to ES97921765T priority patent/ES2285734T3/es
Priority to EP97921765A priority patent/EP0907724B1/de
Priority to DE69737500T priority patent/DE69737500T2/de
Priority to AT97921765T priority patent/ATE357510T1/de
Priority to CA2253246A priority patent/CA2253246C/en
Priority to JP9538572A priority patent/JP2000508918A/ja
Publication of ATA77096A publication Critical patent/ATA77096A/de
Application granted granted Critical
Publication of AT404554B publication Critical patent/AT404554B/de
Priority to JP2008195106A priority patent/JP2008289498A/ja

Links

AT77096A 1996-04-29 1996-04-29 Pharmazeutische präparation AT404554B (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AT77096A AT404554B (de) 1996-04-29 1996-04-29 Pharmazeutische präparation
US08/656,589 US6068838A (en) 1996-04-29 1996-05-31 Purified multimerase
PT97921765T PT907724E (pt) 1996-04-29 1997-04-25 Multimerase do factor de von willebrand
PCT/EP1997/002131 WO1997041206A2 (en) 1996-04-29 1997-04-25 Von willebrand factor multimerase
ES97921765T ES2285734T3 (es) 1996-04-29 1997-04-25 Multimerasa purificada.
EP97921765A EP0907724B1 (de) 1996-04-29 1997-04-25 Von willebrand-faktor multimerase
DK97921765T DK0907724T3 (da) 1996-04-29 1997-04-25 Von Willebrand-faktor-multimerase
DE69737500T DE69737500T2 (de) 1996-04-29 1997-04-25 Gereinigte Multimerase
AT97921765T ATE357510T1 (de) 1996-04-29 1997-04-25 Von willebrand-faktor multimerase
CA2253246A CA2253246C (en) 1996-04-29 1997-04-25 Purified multimerase
JP9538572A JP2000508918A (ja) 1996-04-29 1997-04-25 精製されたマルチメラーゼ
JP2008195106A JP2008289498A (ja) 1996-04-29 2008-07-29 精製されたマルチメラ−ゼ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT77096A AT404554B (de) 1996-04-29 1996-04-29 Pharmazeutische präparation

Publications (2)

Publication Number Publication Date
ATA77096A true ATA77096A (de) 1998-05-15
AT404554B AT404554B (de) 1998-12-28

Family

ID=3499303

Family Applications (1)

Application Number Title Priority Date Filing Date
AT77096A AT404554B (de) 1996-04-29 1996-04-29 Pharmazeutische präparation

Country Status (1)

Country Link
AT (1) AT404554B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation

Also Published As

Publication number Publication date
AT404554B (de) 1998-12-28

Similar Documents

Publication Publication Date Title
DE69525148D1 (de) Pharmazeutische formulierung
DE59712959D1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
ID24654A (id) Formulasi farmasi omeprazola
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
ATE221374T1 (de) Lyophilisierte stabile pharmazeutische formulierung
ATE222751T1 (de) Pharmazeutische aerosolzusammensetzung
DE59915033D1 (de) Pharmazeutische Zubereitung
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
DE59910298D1 (de) Pharmazeutische levothyroxinzubereitung
EP0907644A4 (de) Pharmazeutische zubereitung
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
ID16781A (id) Formulasi-formulasi farmasi
DE69614407D1 (de) Pharmazeutische zusammensetzungen
ATE295150T1 (de) Pharmazeutische zusammensetzungen
ATE208364T1 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung
ITMI941169A0 (it) Formulazioni farmaceutiche
EE03511B1 (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
ID18698A (id) Komposisi farmasi
EP1124557A4 (de) Pharmazeutische zusammensetzung
FI951155A7 (fi) Farmaseuttinen valmiste
DE19681529D2 (de) Pharmazeutische Darreichungsform
ITMI962628A0 (it) Composizione farmaceutica

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
MK07 Expiry

Effective date: 20160429

PC Change of the owner

Owner name: BAXALTA INCORPORATED, US

Effective date: 20160623

Owner name: BAXALTA GMBH, CH

Effective date: 20160623